- Home
- IOVA vs DNP Comparison
IOVA vs DNP Comparison
Compare IOVA & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- DNP
- Stock Information
- Founded
- IOVA 2007
- DNP 1986
- Country
- IOVA United States
- DNP United States
- Employees
- IOVA N/A
- DNP N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- DNP Investment Managers
- Sector
- IOVA Health Care
- DNP Finance
- Exchange
- IOVA Nasdaq
- DNP Nasdaq
- Market Cap
- IOVA 3.0B
- DNP 3.1B
- IPO Year
- IOVA N/A
- DNP N/A
- Fundamental
- Price
- IOVA $8.18
- DNP $9.25
- Analyst Decision
- IOVA Strong Buy
- DNP
- Analyst Count
- IOVA 9
- DNP 0
- Target Price
- IOVA $23.33
- DNP N/A
- AVG Volume (30 Days)
- IOVA 7.2M
- DNP 708.8K
- Earning Date
- IOVA 11-07-2024
- DNP 01-01-0001
- Dividend Yield
- IOVA N/A
- DNP 8.63%
- EPS Growth
- IOVA N/A
- DNP N/A
- EPS
- IOVA N/A
- DNP N/A
- Revenue
- IOVA $90,858,000.00
- DNP N/A
- Revenue This Year
- IOVA $13,827.67
- DNP N/A
- Revenue Next Year
- IOVA $183.70
- DNP N/A
- P/E Ratio
- IOVA N/A
- DNP N/A
- Revenue Growth
- IOVA 12751.20
- DNP N/A
- 52 Week Low
- IOVA $4.44
- DNP $8.09
- 52 Week High
- IOVA $18.33
- DNP $11.18
- Technical
- Relative Strength Index (RSI)
- IOVA 32.59
- DNP 38.62
- Support Level
- IOVA $9.31
- DNP $9.14
- Resistance Level
- IOVA $10.86
- DNP $9.53
- Average True Range (ATR)
- IOVA 0.71
- DNP 0.17
- MACD
- IOVA -0.37
- DNP -0.01
- Stochastic Oscillator
- IOVA 1.48
- DNP 26.36
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.